ADNT Stock Analysis: Adient | NYSE
Auto Parts | NYSE, USA | Market Cap: 1.522m USD | 12M Return: -12.7% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 22.6M
EPS Trend: -43.1%
Qual. Beats: 0
Rev. Trend: -72.5%
Qual. Beats: 2
Warnings
Tailwinds
No distinct edge detected
Seasonality 9.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Adient plc (NYSE: ADNT) is an Ireland-based global supplier of automotive seating systems and components, incorporated in 2016 following its spin-off from Johnson Controls. The company designs, manufactures, and markets complete seating systems and individual components-including mechanisms, frames, foams, head restraints, armrests, and trim covers-for passenger cars, commercial vehicles, and light trucks. Headquartered in Dublin, Adient operates as a tier-1 supplier serving automotive original equipment manufacturers (OEMs) across North America, South America, Europe, the Middle East, Africa, and Asia. The company sits within the Consumer Discretionary sector (Automotive Parts & Equipment sub-industry), where revenue is closely tied to global vehicle production volumes, OEM platform schedules, and pricing pass-through for raw material fluctuations such as steel and foam inputs. As a tier-1 seating specialist, Adient typically competes against other large seating integrators, and its financial performance is heavily influenced by customer concentration among a handful of major global automakers.
- North American OEM production volumes drive seating revenue
- Steel and foam raw material costs pressure seat margins
- Asia joint venture earnings swing with China auto demand
| Net Income: 59.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA 0.34 > 1.0 |
| NWC/Revenue: 2.52% < 20% (prev 2.66%; Δ -0.14% < -1%) |
| CFO/TA 0.06 > 3% & CFO 552.0m > Net Income 59.0m |
| Net Debt (1.56b) to EBITDA (776.0m): 2.01 < 3 |
| Current Ratio: 1.10 > 1.5 & < 3 |
| Outstanding Shares: last quarter (79.3m) vs 12m ago -5.60% < -2% |
| Gross Margin: 6.34% > 18% (prev 6.46%; Δ -0.12% > 0.5%) |
| Asset Turnover: 169.5% > 50% (prev 167.5%; Δ 2.08% > 0%) |
| Interest Coverage Ratio: 2.03 > 6 (EBIT TTM 450.0m / Interest Expense TTM 222.0m) |
| A: 0.04 (Total Current Assets 4.25b - Total Current Liabilities 3.87b) / Total Assets 9.03b |
| B: -0.13 (Retained Earnings -1.16b / Total Assets 9.03b) |
| C: 0.05 (EBIT TTM 450.0m / Avg Total Assets 8.81b) |
| D: 0.25 (Book Value of Equity 1.71b / Total Liabilities 6.94b) |
| Altman-Z'' = 0.46 = B |
| DSRI: 1.04 (Receivables 2.03b/1.89b, Revenue 14.9b/14.4b) |
| GMI: 1.02 (GM 6.46% / 6.34%) |
| AQI: 0.96 (AQ_t 0.38 / AQ_t-1 0.39) |
| SGI: 1.04 (Revenue 14.9b / 14.4b) |
| TATA: -0.05 (NI 59.0m - CFO 552.0m) / TA 9.03b) |
| Beneish M = -2.98 (Cap -4..+1) = A |
As of July 11, 2026, the stock is trading at USD 19.96 with a total of 608,808 shares traded. Over the past week, the price has changed by +6.40%, over one month by -8.10%, over three months by -2.25% and over the past year by -12.72%.
Current recommended Stop Loss: 18.60 (which is 6.8% or 1.4 ATR below the current price).
Adient has received a consensus analysts rating of 3.08. Therefore, it is recommended to hold ADNT.
- StrongBuy: 2
- Buy: 0
- Hold: 8
- Sell: 1
- StrongSell: 1
| Analysts Target Price | 31.8 | 59.1% |
P/E Trailing = 29.8615
P/E Forward = 5.9172
P/S = 0.1019
P/B = 0.8587
P/EG = 0.1362
Revenue TTM = 14.9b USD
EBIT TTM = 450.0m USD
EBITDA TTM = 776.0m USD
Long Term Debt = 2.38b USD (from longTermDebt, last quarter)
Short Term Debt = 9.00m USD (from shortTermDebt, last quarter)
Debt = 2.39b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.56b USD (calculated: Debt 2.39b - CCE 831.0m)
Enterprise Value = 3.08b USD (1.52b + Debt 2.39b - CCE 831.0m)
Interest Coverage Ratio = 2.03 (Ebit TTM 450.0m / Interest Expense TTM 222.0m)
EV/FCF = 11.08x (Enterprise Value 3.08b / FCF TTM 278.0m)
FCF Yield = 9.03% (FCF TTM 278.0m / Enterprise Value 3.08b)
FCF Margin = 1.86% (FCF TTM 278.0m / Revenue TTM 14.9b)
Net Margin = 0.39% (Net Income TTM 59.0m / Revenue TTM 14.9b)
Gross Margin = 6.34% ((Revenue TTM 14.9b - Cost of Revenue TTM 14.0b) / Revenue TTM)
Gross Margin QoQ = 6.36% (prev 5.95%)
Tobins Q-Ratio = 0.34 (Enterprise Value 3.08b / Total Assets 9.03b)
Interest Expense / Debt = 9.30% (Interest Expense 222.0m / Debt 2.39b)
Taxrate = 43.32% (107.0m / 247.0m)
NOPAT = 255.1m (EBIT 450.0m * (1 - 43.32%))
Current Ratio = 1.10 (Total Current Assets 4.25b / Total Current Liabilities 3.87b)
Debt / Equity = 1.39 (Debt 2.39b / totalStockholderEquity, last quarter 1.71b)
Debt / EBITDA = 2.01 (Net Debt 1.56b / EBITDA 776.0m)
Debt / FCF = 5.60 (Net Debt 1.56b / FCF TTM 278.0m)
Total Stockholder Equity = 1.75b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.67% (Net Income 59.0m / Total Assets 9.03b)
RoE = 3.37% (Net Income TTM 59.0m / Total Stockholder Equity 1.75b)
RoCE = 10.90% (EBIT 450.0m / Capital Employed (Equity 1.75b + L.T.Debt 2.38b))
RoIC = 5.77% (NOPAT 255.1m / Invested Capital 4.42b)
WACC = 7.94% (E(1.52b)/V(3.91b) * Re(12.13%) + D(2.39b)/V(3.91b) * Rd(9.30%) * (1-Tc(0.43)))
Discount Rate = 12.13% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -91.11 | Cagr: -7.10%
[DCF] Terminal Value 77.97% ; FCFF base≈260.8m ; Y1≈299.0m ; Y5≈440.0m
[DCF] Fair Price = 64.58 (EV 6.62b - Net Debt 1.56b = Equity 5.06b / Shares 78.4m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -43.10 | EPS CAGR: -4.38% | SUE: 0.42 | # QB: 0
Revenue Correlation: -72.55 | Revenue CAGR: -2.02% | SUE: 2.40 | # QB: 2
EPS current Quarter (2026-06-30): EPS=0.54 | Chg30d=-2.59% | Revisions=-17% | Analysts=12
EPS current Year (2026-09-30): EPS=2.12 | Chg30d=-0.49% | Revisions=+27% | GrowthEPS=+9.9% | GrowthRev=+2.2%
EPS next Year (2027-09-30): EPS=3.30 | Chg30d=-1.43% | Revisions=-50% | GrowthEPS=+55.6% | GrowthRev=+1.8%
[Analyst] Revisions Ratio: +0% (up=9, down=9)